Ofer Sharon is the founder of OncoHost. OncoHost has raised $45M in total funding. Latest round: Series C.
Dr. Ofer Sharon is the CEO of OncoHost, a precision oncology biotech company that develops the PROphet host response profiling platform. He is a physician by training with experience in pharma drug development and entrepreneurship. OncoHost launched PROphet for non-small cell lung cancer in the U.S. in February 2023.
Full founder directory · Investor directory · Company funding database · Fundraising library